Herz-Kreislauf-Check (Cardiovascular Risk Assessment)

Advanced cardiovascular risk screening analyzing 10 biomarkers for heart attack, stroke, and atherosclerosis risk assessment. Venous blood sample with 12-hour fasting required. Same-day results available. Essential for: family history of heart disease, over age 40, smokers, diabetes, hypertension, high cholesterol, obesity, sedentary lifestyle. Identifies modifiable risk factors before cardiovascular events occur. Biomarkers tested: Lipid Panel - total cholesterol (overall risk), HDL cholesterol ("good" protective cholesterol, target >40 mg/dL men, >50 mg/dL women), LDL cholesterol ("bad" cholesterol causing arterial plaque, target <100 mg/dL, <70 mg/dL high-risk patients), triglycerides (fat metabolism, independent risk factor when elevated); Advanced Cardiovascular Markers - lipoprotein(a) [Lp(a)] (genetic cardiovascular risk factor unaffected by lifestyle, strong predictor of heart attack/stroke even with normal cholesterol, elevated levels >30 mg/dL require aggressive LDL management), homocysteine (amino acid, elevated levels (>15 µmol/L) damage arterial walls promoting atherosclerosis, linked to B vitamin deficiency); Blood Count - complete blood count (anemia affects oxygen delivery to heart, polycythemia increases blood viscosity and clot risk); Metabolism - fasting glucose (diabetes damages vessels accelerating atherosclerosis), HbA1c (long-term glucose control, diabetes/prediabetes screening); Kidney - creatinine (kidney disease accelerates cardiovascular disease). Panel provides comprehensive cardiovascular risk stratification beyond basic cholesterol testing. Lp(a) testing particularly valuable as this genetic risk factor often overlooked in standard screening but affects 20% of population. Homocysteine identifies treatable risk factor (lowered with B vitamins). Results guide: statin therapy initiation, aspirin therapy, blood pressure management, diabetes treatment, lifestyle modifications (diet, exercise, smoking cessation). Recommended frequency: baseline age 40, annually if high risk, every 3-5 years if low risk. GOÄ pricing €93.16.

A lipid panel measures the fats and fatty substances in your blood that are key indicators of cardiovascular risk. The standard panel includes total cholesterol, LDL ("bad") cholesterol, HDL ("good") cholesterol, and triglycerides. Advanced panels may also measure ApoB, Lp(a), and lipoprotein particle size — markers that more accurately predict heart disease risk than standard cholesterol alone. Cardiovascular disease remains the leading cause of death worldwide, and lipid testing is one of the most effective tools for early risk detection. Regular monitoring allows you to track the impact of diet, exercise, and medication on your cardiovascular health.